While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
Although the medtech industry is expected to enjoy steady growth, device companies are still challenged to attract the skilled labor that manufacturing requires.
Analysts expect 2020 to be a busy year for M&A activity.
The outlook for 2020 and beyond is positive, but medical device companies must continue to evolve their technologies and partnerships to keep the attention of investors.
How will you make your company more attractive to investors?
Eighty medtech transactions in Europe came in at a value of approximately $627.5 million.
Peter Micca of Deloitte discusses the changes that are happening within the healthcare ecosystem as a whole.
The total value of deals for 2019 exceeds $30 billion.
Overall activity in deals jumped 11% in North America.
The order settles anti-competitive charges related to vascular closure devices.